An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX ® in Patients With Hemophilia B

Condition:   Hemophilia B Interventions:   Genetic: HEMGENIX;   Biological: Factor IX (FIX) Sponsor:   CSL Behring Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials